These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 39044334)
1. Cost-Utility Analysis of Bilateral Cochlear Implants for Children With Severe-to-Profound Sensorineural Hearing Loss in Taiwan. Lin TH; Lin PH; Fang TY; Wu CC; Wang PC; Ko Y Ear Hear; 2024 Jul; ():. PubMed ID: 39044334 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of bilateral cochlear implants for children with severe-to-profound sensorineural hearing loss in both ears in Singapore. Cheng LJ; Soon SS; Wu DB; Ju H; Ng K PLoS One; 2019; 14(8):e0220439. PubMed ID: 31415595 [TBL] [Abstract][Full Text] [Related]
3. The Cost-Effectiveness of Bimodal Stimulation Compared to Unilateral and Bilateral Cochlear Implant Use in Adults with Bilateral Severe to Profound Deafness. Theriou C; Fielden CA; Kitterick PT Ear Hear; 2019; 40(6):1425-1436. PubMed ID: 30998548 [TBL] [Abstract][Full Text] [Related]
4. Implantable Devices for Single-Sided Deafness and Conductive or Mixed Hearing Loss: A Health Technology Assessment. Ontario Health (Quality) Ont Health Technol Assess Ser; 2020; 20(1):1-165. PubMed ID: 32194878 [TBL] [Abstract][Full Text] [Related]
5. Cost-Utility Analysis of Cochlear Implantation in Australian Adults. Foteff C; Kennedy S; Milton AH; Deger M; Payk F; Sanderson G Otol Neurotol; 2016 Jun; 37(5):454-61. PubMed ID: 26963668 [TBL] [Abstract][Full Text] [Related]
6. The effectiveness and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults: a systematic review and economic model. Bond M; Mealing S; Anderson R; Elston J; Weiner G; Taylor RS; Hoyle M; Liu Z; Price A; Stein K Health Technol Assess; 2009 Sep; 13(44):1-330. PubMed ID: 19799825 [TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness of Pediatric Cochlear Implantation in Rural China. Qiu J; Yu C; Ariyaratne TV; Foteff C; Ke Z; Sun Y; Zhang L; Qin F; Sanderson G Otol Neurotol; 2017 Jul; 38(6):e75-e84. PubMed ID: 28379918 [TBL] [Abstract][Full Text] [Related]
8. Economic Evaluation of Treatments for Pediatric Bilateral Severe to Profound Sensorineural Hearing Loss: An Australian Perspective. Foteff C; Kennedy S; Milton AH; Deger M; Payk F; Sanderson G Otol Neurotol; 2016 Jun; 37(5):462-9. PubMed ID: 26963667 [TBL] [Abstract][Full Text] [Related]
9. Cost-effective analysis of unilateral cochlear implantation under the Taiwan national healthcare insurance. Fang TY; Cheng LJ; Wu DB; Wang PC Int J Audiol; 2020 Jan; 59(1):39-44. PubMed ID: 31498005 [No Abstract] [Full Text] [Related]
10. Bilateral Cochlear Implantation: A Health Technology Assessment. Health Quality Ontario Ont Health Technol Assess Ser; 2018; 18(6):1-139. PubMed ID: 30443278 [TBL] [Abstract][Full Text] [Related]
11. A cost-utility analysis of cochlear implants for single sided deafness in adults and children in the Netherlands. van Lieshout C; Abraham K; Smit AL; Frederix GWJ PLoS One; 2024; 19(8):e0307881. PubMed ID: 39102399 [TBL] [Abstract][Full Text] [Related]
12. Economic Analysis of Cochlear Implants in Adults With Bilateral Severe-to-Profound Hearing Loss. A Systematic Review of the Literature. Tena-García B; Barrientos-Trigo S; Escudero-Carretero MJ; Sánchez-Gómez S Otol Neurotol; 2024 Aug; 45(7):717-731. PubMed ID: 38896785 [TBL] [Abstract][Full Text] [Related]
14. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation. Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840 [TBL] [Abstract][Full Text] [Related]
15. Bone-anchored hearing aids (BAHAs) for people who are bilaterally deaf: a systematic review and economic evaluation. Colquitt JL; Jones J; Harris P; Loveman E; Bird A; Clegg AJ; Baguley DM; Proops DW; Mitchell TE; Sheehan PZ; Welch K Health Technol Assess; 2011 Jul; 15(26):1-200, iii-iv. PubMed ID: 21729632 [TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Sorafenib Monotherapy and Selected Combination Therapy with Sorafenib in Patients with Advanced Hepatocellular Carcinoma. Ho JC; Hsieh ML; Chuang PH; Hsieh VC Value Health Reg Issues; 2018 May; 15():120-126. PubMed ID: 29704658 [TBL] [Abstract][Full Text] [Related]
17. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model. Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842 [TBL] [Abstract][Full Text] [Related]
18. Cost-utility analysis of inotuzumab ozogamicin for relapsed or refractory B cell acute lymphoblastic leukemia from the perspective of Taiwan's health care system. Lee TY; Chen HY; Chen TY; Li SS; Fang WT; Wen YC; Lo YW; Ou HT Eur J Health Econ; 2020 Sep; 21(7):1105-1116. PubMed ID: 32506280 [TBL] [Abstract][Full Text] [Related]
19. Cost-utility analysis of bilateral cochlear implantation in adults: a health economic assessment from the perspective of a publicly funded program. Chen JM; Amoodi H; Mittmann N Laryngoscope; 2014 Jun; 124(6):1452-8. PubMed ID: 24431194 [TBL] [Abstract][Full Text] [Related]